Ticker Tape by TradingView
The global market for drug pain relief is over $60 Billion/yr. Beleave is exploring a natural alternative in cannabis.With their recent license to cultivate cannabis, Beleave, alongside Ryerson and McMaster University, is pioneering a new industry.Beleave Inc. is a biotech company focused on the production of medical marijuana in Canada.The Company’s wholly-owned subsidiary First Access Medical Inc. has received a license to cultivate medical marijuana. At its facility pursuant to the Access to Cannabis for Medical Purposes Regulations outlined by Health Canada.The Company is actively working towards its sales license, the development of patents through research with Canadian institutions. And the research and development of smoke harm reduction products.Beleave Inc. is pleased to announce that it is now beginning work on a technological development research project at Ryerson University. With the goal of developing and validating technologies that are able to quantify micronutrient and heavy metal content in the cannabis plant, in real time.This project is geared to above all help authorized cannabis cultivators optimize their cultivation process and allow them to rapidly evaluate quality assurance metrics of finished products.For more information on Beleave Inc. (BE.CN) please fill out the form below.